About Rheumera
Rheumera is a Healthcare company based in Washington (United States) founded in 2023 by Shawn Studdard, Navneet Gosal, and Micah McClelland. Patients and rheumatology specialists are connected through an app-based platform. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Patient Engagement. Its legal entity in India is Rheumera India Private Limited (U63999PB2023FTC059917). Similar companies include Zimmer Biomet, CipherHealth and ConnectiveRx; 2 of its 3 listed similar companies have raised funding.
Company details
Founded in 2023, Rheumera operates as an app-based platform in the rheumatology healthcare sector. Connections between patients and specialists are facilitated, with digital assessment tools provided for both in-office and remote applications. Patient progress is monitored in real-time, and updates on reported outcomes are shared with physicians. Care plans are developed using data submitted by patients. Users are enabled to interact with the platform and participate actively in care management.
- Headquarters Washington, United States
- Founders Shawn Studdard, Navneet Gosal, Micah McClelland
- SectorsHealthcare
- Email••••••••
- Website rheumera.com
- Social LinkedIn
- Legal Name Rheumera India Private Limited
- Date of Incorporation 30 Oct, 2023
- Jurisdiction Mohali, Punjab, India
Associated legal entities of Rheumera
Rheumera operates through Rheumera India Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rheumera India Private Limited CIN U63999PB2023FTC059917 | Active | 30 Oct 2023 | Mohali, Punjab | 4 | 2 | View details |
Board of directors of Rheumera India Private Limited (Rheumera)
Rheumera India Private Limited is the primary company behind Rheumera. The board of Rheumera India Private Limited currently have 2 directors; the longest-serving is Poonam Aggarwal, appointed in 2023. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Poonam Aggarwal DIN 10311204 | Director | 30 Oct 2023 | 3 yrs | Rheumera India Private Limited |
| Deepak Aggarwal DIN 02673756 | Director | 30 Oct 2023 | 3 yrs | Rheumera India Private Limited |
People of Rheumera
5 people are tracked at Rheumera (5 in leadership).
| Name | Role | Group |
|---|---|---|
Shawn Studdard | Co-Founder | Leadership |
Navneet Gosal | Co-Founder | Leadership |
Micah McClelland | Co-Founder | Leadership |
Cassandra Lang | Head Of Product | Leadership |
Adam Bruner | Chief Financial Officer | Leadership |
Complete people profiles for Rheumera
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Similar companies to Rheumera
Rheumera has 3 listed similar companies in our database, 2 of them funded. They include Zimmer Biomet, CipherHealth and ConnectiveRx.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| zimmerbiomet.com | 1927 | Warsaw, United States | 18,000 | Medical devices for multiple health purposes are manufactured. | ||
| cipherhealth.com | 2009 | New York, United States | $37.58M | SaaS based tools for patient engagement | ||
| connectiverx.com | 2008 | Hanover, United States | $300M | 684 | Provider of patient engagement and prior authorization solutions |
Detailed similar companies of Rheumera
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Clinical IT & Data Platforms
3 companies that operate in the same segment as Rheumera (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Employee health benefits are facilitated via a cloud-based platform. | 2007 | Plymouth Meeting, Pennsylvania, United States | USD 228.3 M | |||
Healthcare appointments are booked online via Zocdoc's platform. | 2007 | New York, New York, United States | USD 425.97 M | USD 4.66 M | 1,365 | |
Virtual physical therapy and digital pain care solutions are provided. | 2015 | San Francisco, California, United States | USD 854.44 M | 1,746 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rheumera
Rheumera was founded in 2023.
Rheumera is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Founded in 2023, Rheumera operates as an app-based platform in the rheumatology healthcare sector. Connections between patients and specialists are facilitated, with digital assessment tools provided for both in-office and remote applications. Patient progress is monitored in real-time, and updates on reported outcomes are shared with physicians. Care plans are developed using data submitted by patients. Users are enabled to interact with the platform and participate actively in care management.
Rheumera's top competitors include CipherHealth, ConnectiveRx and Zimmer Biomet.
Rheumera operates through Rheumera India Private Limited.
The legal entities of Rheumera currently have 2 directors, including Poonam Aggarwal, Deepak Aggarwal.